Drugs / Klean-Prep®
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy5 trials | ||||||
| Phase 1 | NCT00896246 Comparator | Sep → Oct 2006 | — | Norgine | Completed | No outcome recorded |
| Phase 3 | NCT03992365 Comparator | Jun → Oct 2019 | — | Universal Integrated Corp. | Completed | No outcome recorded |
| Phase 3 | NCT03008460 Comparator | Oct 2017 → Feb 2020 | digestive system disorder | Ipsen | Completed | Missed primary |
| Phase 4 | NCT04474002 Comparator | Dec 2020 → Dec 2022 | — | Queen Elizabeth Hospital, Hong Kong | Completed | No outcome recorded |
| Phase 4 | NCT03351972 Comparator | Nov 2017 → Mar 2025 | celiac disease, inflammatory bowel disease | Sheffield Teaching Hospitals NHS Foundation Trust | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Klean-prep | “About 4 hours after administration of Dulcolax®, drink the 1000 ml Klean-Prep solution at a rate of 250 ml every 15 minutes” NCT03992365 ↗5“either a split dose of 4L PEG + Electrolyte (Klean-prep® ) or 1L Klean-prep® plus 2 sachets SPMC (Picoprep®).” NCT04474002 ↗ |
| Known as | polyethylene glycol (PEG)-electrolytes | “Klean-Prep® (polyethylene glycol (PEG)-electrolytes)” NCT03008460 ↗ |
| Modality | Other / unclassified | “polyethylene glycol (PEG)-electrolyte solution” PMID 36821851 ↗ Feb 2023 |
| Route | Oral | “Four litres of solution administered orally as a divided dose.” NCT00896246 ↗ |